Cargando…
Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts
Oral cavity squamous cell carcinomas (OSCCs) are aggressive tumors, and their recurrence leads to poor prognosis and reduced survival rates. This study aimed to identify therapeutic targets and to evaluate the efficacy of targeted inhibitors in OSCC patient-derived xenograft (PDX) models. Herein, we...
Autores principales: | Yang, Chia-Yu, Liu, Chiao-Rou, Chang, Ian Yi-Feng, OuYang, Chun-Nan, Hsieh, Chia-Hsun, Huang, Yen-Lin, Wang, Chun-I, Jan, Fei-Wen, Wang, Wan-Ling, Tsai, Ting-Lin, Liu, Hsuan, Tseng, Ching-Ping, Chang, Yu-Sun, Wu, Chih-Ching, Chang, Kai-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408003/ https://www.ncbi.nlm.nih.gov/pubmed/32610557 http://dx.doi.org/10.3390/cancers12071726 |
Ejemplares similares
-
Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma
por: Yen, Wei-Chen, et al.
Publicado: (2022) -
Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia
por: Wang, Tingting, et al.
Publicado: (2019) -
ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer
por: Li, Ching-Chia, et al.
Publicado: (2015) -
Cotargeting among microRNAs in the brain
por: Cherone, Jennifer M., et al.
Publicado: (2019) -
Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3
por: Lai, F, et al.
Publicado: (2013)